Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine for treatment of methamphetamine use disorder
IRCT20240915063046N1Phase 3Completed
- Sponsor
- University of Social Welfare and Rehabilitation Sciences
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mirtazapine in methamphetamine use disorder (MUD), sponsored by University of Social Welfare and Rehabilitation Sciences. Started Sep 2024; status: completed.
02
Drugs
mirtazapine
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on IRCT20240915063046N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240915063046N1.